Protein-Centric Omics Analysis Reveals Circulating Complements Linked to Non-Viral Liver Diseases as Potential Therapeutic Targets
CONCLUSIONS: Our study suggests that certain complement components, including C1S, C1QC, CFHR1, CFHR2, CFHR5, C7, and C8G, might play a role in non-viral liver diseases and could be potential targets for drug development.PMID:38061333 | DOI:10.3350/cmh.2023.0343
Source: Clinical and molecular hepatology - Category: Gastroenterology Authors: Yingzhou Shi Hang Dong Shiwei Sun Xiaoqin Wu Jiansong Fang Jianbo Zhao Junming Han Zhongyue Li Huixiao Wu Luna Liu Wanhong Wu Yang Tian Guandou Yuan Xiude Fan Chao Xu Source Type: research
More News: Alcoholism | Autoimmune Disease | Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Genetics | Hepatitis | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Men | Molecular Biology | Study | Urology & Nephrology